Albanis Efsevia, Friedman Scott L
Division of Liver Diseases, Mount Sinai Medical Center, 1425 Madison Avenue, New York, NY 10029, USA.
Clin Liver Dis. 2006 Nov;10(4):821-33. doi: 10.1016/j.cld.2006.08.027.
Chronic hepatitis C (HCV) infection leads to the development of hepatic fibrosis. No single test for diagnosing liver fibrosis is completely optimal. The ability to assess the extent and progression of fibrosis is important in the clinical setting, especially in the context of current treatments and therapeutic trials. More accurate and noninvasive methods to diagnose and monitor fibrosis are needed, because these trials will require serial evaluations of liver fibrosis to assess a compound's antifibrotic effect.
慢性丙型肝炎(HCV)感染会导致肝纤维化的发展。没有一种用于诊断肝纤维化的单一检测方法是完全理想的。在临床环境中,评估纤维化的程度和进展的能力很重要,尤其是在当前治疗和治疗试验的背景下。需要更准确且无创的方法来诊断和监测纤维化,因为这些试验将需要对肝纤维化进行系列评估,以评估一种化合物的抗纤维化作用。